Literature DB >> 8039637

Neutrophil autoantibodies in inflammatory bowel disease: are they important?

F Shanahan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8039637     DOI： 10.1016/0016-5085(94)90189-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  10 in total

Review 1.  Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)?

Authors:  C Roozendaal; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

2.  Perinuclear anti-neutrophil cytoplasmic antibodies (p-anca) in chronic ulcerative colitis: experience in a Mexican institution.

Authors:  Jesus K Yamamoto-Furusho; Takeshi Takahashi-Monroy; Omar Vergara-Fernandez; Edgardo Reyes; Luis Uscanga
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

3.  Antibody 'markers' in Crohn's disease: opportunity or overstatement?

Authors:  F Shanahan
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

4.  Antineutrophil cytoplasmic antibodies in sera from colectomised ulcerative colitis patients and its relation to the presence of pouchitis.

Authors:  M Esteve; J Mallolas; J Klaassen; A Abad-Lacruz; F González-Huix; E Cabré; F Fernández-Bañares; X Bertrán; E Condom; J Martí-Ragué; M A Gassull
Journal:  Gut       Date:  1996-06       Impact factor: 23.059

Review 5.  Immunopathology of human inflammatory bowel disease.

Authors:  P Brandtzaeg; G Haraldsen; J Rugtveit
Journal:  Springer Semin Immunopathol       Date:  1997

6.  Catalase and alpha-enolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD).

Authors:  C Roozendaal; M H Zhao; G Horst; C M Lockwood; J H Kleibeuker; P C Limburg; G F Nelis; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

7.  Anti-pancreatic antibody in Turkish patients with inflammatory bowel disease and first-degree relatives.

Authors:  Huseyin Demirsoy; Kamil Ozdil; Ozdal Ersoy; Besir Kesici; Cetin Karaca; Canan Alkim; Nihat Akbayir; Levent Kamil Erdem; Mehmet Derya Onuk; Hulya Tugrul Beyzadeoglu
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

Review 8.  Current concepts of the pathogenesis of inflammatory bowel disease.

Authors:  F Shanahan
Journal:  Ir J Med Sci       Date:  1994-12       Impact factor: 1.568

9.  Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease with special attention for IgA-class antibodies.

Authors:  P Gigase; L S De Clerck; K A Van Cotthem; C H Bridts; W J Stevens; M Van Outryve; P A Pelckmans
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199

10.  Lack of effect of antineutrophil cytoplasmic antibodies associated with ulcerative colitis on superoxide anion production from neutrophils.

Authors:  P Gionchetti; M Vecchi; F Rizzello; M Ferretti; C Calabresi; A Venturi; M B Bianchi; C Brignola; R A Sinico; R De Franchis; M Miglioli; M Campieri
Journal:  Gut       Date:  1997-01       Impact factor: 23.059
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.